We received notification that our R01 on xylazine and fentanyl co-use will be funded by NIDA on June 15, titled “Neurobehavioral mechanisms of xylazine and fentanyl co-use and withdrawal“. This grant will determine the behavioral and neurobiological impacts of xylazine adulteration of intravenously self-administered fentanyl in collaboration with Dr. Terry Hinds, Jr., and will utilize his state-of-the-art Pamgene Pamstation to uncover novel targets to reverse overdose.
Recent Posts
- January, 2024
Congratulations to Safiyah Sadek on her first-author publication on xylazine and fentanyl!
Tyrone Kendrick Wins Award!
- December, 2023
ACNP 2023 was a success!
- November, 2023
Shailesh’s Goodbye Party!
- October, 2023
Gipson Lab Feature: PodCast for Neuropsychopharmacology on Xylazine Adulteration of Fentanyl
Categories
- Recent News
- Uncategorized
- more